Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Canada Research Chairs

Université de Montréal

$70,000.00

Responsible Multi-omics Data Science

EF 2024-25

Résumé
In our research program, we will leverage the power of data science, biotechnology, and bioinformatics to address urgent public health challenges and unravel the complex dynamics of life on Earth. In this new era of artificial intelligence (AI), this research chair will be structured around three principal axes: 1) Equity in AI for biomedical research: We aim to develop AI methods, utilizing machine learning and bioinformatics, to ensure equity and inclusivity in the processing and analysis of molecular ('omics') data. Our goal is to create algorithms and models that are devoid of biases, thus making the benefits of AI accessible and fair for all, particularly in the field of healthcare and biological research. 2) Pandemic Preparedness Strategies Based on Omics Data: In response to the challenges posed by events such as the COVID-19 pandemic, our focus will shift towards utilizing omics data to enhance preparedness and response mechanisms for future pandemics. By leveraging the vast datasets available in genomics, proteomics, and other omics fields, we aim to build predictive models that can anticipate outbreak patterns and inform more effective public health strategies. 3) Evolution of Cytochrome P450 (CYP) Genes and Pseudogenes: Our research will delve into the evolutionary history of the CYP gene family, which plays a crucial role in a wide range of metabolic processes not only in humans but also in primates and eventually in plants. This axis aims to explore the genetic adaptations that have allowed these genes to perform essential functions across different species, contributing to our understanding of biological diversity and evolution. Finally, my commitment to the development of bioinformatics training programs at the Université de Montréal and on a pan-Canadian scale underscores my dedication to nurturing the next generation of scientists. I aim to create a rich and diverse interdisciplinary learning environment where students can engage with the latest technologies and approaches in AI for life and health sciences.
Programme
Canada Research Chairs
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
CRC-2024-00027
Name nom
Hussin, Julie
Department département
Medecine - Université de Montréal
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
70000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF1020801
Field of research list names en
Algorithms and computational genomics
Field of research list names fr
Algorithmes et informatique appliquée à la génomique
Socioeconomic objective list codes
RDS10701
Socioeconomic objective list names en
Human health procedures and pharmaceutical treatments
Socioeconomic objective list names fr
Interventions et traitements pharmaceutiques ayant trait à la santé humaine
Application title
Responsible Multi-omics Data Science
Keywords
genomics; cardiovascular disease; bioinformatics; machine learning; fairness; multi-omics; pandemic preparedness; evolutionary genetics
Application summary
In our research program, we will leverage the power of data science, biotechnology, and bioinformatics to address urgent public health challenges and unravel the complex dynamics of life on Earth. In this new era of artificial intelligence (AI), this research chair will be structured around three principal axes: 1) Equity in AI for biomedical research: We aim to develop AI methods, utilizing machine learning and bioinformatics, to ensure equity and inclusivity in the processing and analysis of molecular ('omics') data. Our goal is to create algorithms and models that are devoid of biases, thus making the benefits of AI accessible and fair for all, particularly in the field of healthcare and biological research. 2) Pandemic Preparedness Strategies Based on Omics Data: In response to the challenges posed by events such as the COVID-19 pandemic, our focus will shift towards utilizing omics data to enhance preparedness and response mechanisms for future pandemics. By leveraging the vast datasets available in genomics, proteomics, and other omics fields, we aim to build predictive models that can anticipate outbreak patterns and inform more effective public health strategies. 3) Evolution of Cytochrome P450 (CYP) Genes and Pseudogenes: Our research will delve into the evolutionary history of the CYP gene family, which plays a crucial role in a wide range of metabolic processes not only in humans but also in primates and eventually in plants. This axis aims to explore the genetic adaptations that have allowed these genes to perform essential functions across different species, contributing to our understanding of biological diversity and evolution. Finally, my commitment to the development of bioinformatics training programs at the Université de Montréal and on a pan-Canadian scale underscores my dedication to nurturing the next generation of scientists. I aim to create a rich and diverse interdisciplinary learning environment where students can engage with the latest technologies and approaches in AI for life and health sciences.